
Relay Therapeutics
A new breed of company at the intersection of computation and biotechnology that is committed to creating medicines that will have a transformative impact on patients.
Market cap
$565m
Enterprise value
($98m)
Share price
$3.46 RLAY
Authorizing premium user...